Causal evidence of the relationship between polycystic ovary syndrome and obstructive sleep apnea in European and East Asian populations: a two-sample Mendelian randomization study.
{"title":"Causal evidence of the relationship between polycystic ovary syndrome and obstructive sleep apnea in European and East Asian populations: a two-sample Mendelian randomization study.","authors":"Xueying Liu, Renke He, Kejing Zhu, Zhongliang Lin, Zhaoying Jiang, Haiyan Wu, Jiaen Yu, Qinyu Luo, Jianzhong Sheng, Hefeng Huang","doi":"10.21037/jtd-24-885","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Several studies have documented the high prevalence of obstructive sleep apnea (OSA) among women with polycystic ovary syndrome (PCOS). However, causal relationships between the two conditions remain unconfirmed. This study aims to assess the causal relationships between OSA and PCOS.</p><p><strong>Methods: </strong>We conducted a two-sample Mendelian randomization (MR) analysis utilizing instrumental variables (IVs) derived from large-scale genome-wide association studies (GWAS) to genetically estimate the causal effects of PCOS on OSA. To explore the impact of PCOS on OSA across different ethnicities, we analyzed GWAS data from European and East Asian participants. The inverse variance weighted (IVW) method was the primary statistical approach. A series of sensitivity analyses, including the weighted median, MR-Egger, weighted mode methods, and leave-one-out analysis, were performed to evaluate the robustness of our MR results.</p><p><strong>Results: </strong>In the IVW analysis, the odds ratio (OR) for the association between PCOS and OSA was 1.133 [95% confidence interval (CI): 1.037-1.239, P=0.006], indicating that PCOS significantly increases the risk of OSA in the European population. No evidence of heterogeneity or directional pleiotropy was found using Cochran's Q test and the MR-Egger test. Conversely, the IVW analysis did not reveal a causal effect of PCOS on OSA in the East Asian population (OR =1.061, 95% CI: 0.888-1.268, P=0.51).</p><p><strong>Conclusions: </strong>Our findings suggest that European women with PCOS are at an increased risk for OSA. However, no association was observed between PCOS and OSA in the East Asian population. Clinicians should maintain a high index of suspicion for OSA in women with PCOS, particularly among the European demographic.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7372-7382"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635232/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-885","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Several studies have documented the high prevalence of obstructive sleep apnea (OSA) among women with polycystic ovary syndrome (PCOS). However, causal relationships between the two conditions remain unconfirmed. This study aims to assess the causal relationships between OSA and PCOS.
Methods: We conducted a two-sample Mendelian randomization (MR) analysis utilizing instrumental variables (IVs) derived from large-scale genome-wide association studies (GWAS) to genetically estimate the causal effects of PCOS on OSA. To explore the impact of PCOS on OSA across different ethnicities, we analyzed GWAS data from European and East Asian participants. The inverse variance weighted (IVW) method was the primary statistical approach. A series of sensitivity analyses, including the weighted median, MR-Egger, weighted mode methods, and leave-one-out analysis, were performed to evaluate the robustness of our MR results.
Results: In the IVW analysis, the odds ratio (OR) for the association between PCOS and OSA was 1.133 [95% confidence interval (CI): 1.037-1.239, P=0.006], indicating that PCOS significantly increases the risk of OSA in the European population. No evidence of heterogeneity or directional pleiotropy was found using Cochran's Q test and the MR-Egger test. Conversely, the IVW analysis did not reveal a causal effect of PCOS on OSA in the East Asian population (OR =1.061, 95% CI: 0.888-1.268, P=0.51).
Conclusions: Our findings suggest that European women with PCOS are at an increased risk for OSA. However, no association was observed between PCOS and OSA in the East Asian population. Clinicians should maintain a high index of suspicion for OSA in women with PCOS, particularly among the European demographic.
背景:多项研究表明,患有多囊卵巢综合征(PCOS)的女性中阻塞性睡眠呼吸暂停(OSA)的发病率很高。然而,这两种疾病之间的因果关系仍未得到证实。本研究旨在评估 OSA 与多囊卵巢综合征之间的因果关系:方法:我们利用从大规模全基因组关联研究(GWAS)中获得的工具变量(IVs)进行了双样本孟德尔随机化(MR)分析,从遗传学角度估计多囊卵巢综合征对 OSA 的因果效应。为了探讨不同种族的多囊卵巢综合征对 OSA 的影响,我们分析了欧洲和东亚参与者的 GWAS 数据。反方差加权(IVW)法是主要的统计方法。我们进行了一系列敏感性分析,包括加权中位数法、MR-Egger法、加权模式法和leave-one-out分析,以评估MR结果的稳健性:在IVW分析中,多囊卵巢综合征与OSA之间的相关性的比值比(OR)为1.133[95%置信区间(CI):1.037-1.239,P=0.006],表明多囊卵巢综合征会显著增加欧洲人群患OSA的风险。使用 Cochran's Q 检验和 MR-Egger 检验未发现异质性或方向性多生物效应的证据。相反,在东亚人群中,IVW分析并未发现多囊卵巢综合征对OSA的因果效应(OR =1.061,95% CI:0.888-1.268,P=0.51):我们的研究结果表明,患有多囊卵巢综合症的欧洲女性患 OSA 的风险增加。结论:我们的研究结果表明,患有多囊卵巢综合症的欧洲女性罹患 OSA 的风险增加,但在东亚人群中未观察到多囊卵巢综合症与 OSA 之间存在关联。临床医生应高度怀疑患有多囊卵巢综合症的女性,尤其是欧洲人。
期刊介绍:
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.